Ford orders white-collar workers back to office four days a week: ‘More dynamic company' — Positive
F New York Post — June 25, 2025Businesses around the world have grappled with how much flexibility to allow workers since the 2020 coronavirus pandemic.
Why BlackRock's Rick Rieder is confident in equities in the second half as S&P 500 nears high — Positive
BLK IVV SPLG SPXL SPY SSO UPRO VOO CNBC — June 25, 2025BlackRock's Rick Rieder is confident a stock market nearing all-time highs can go even as inflation comes down because of artificial intelligence.
PBF Outperforms Industry in 3 Months: How to Play the Stock? — Neutral
PBF Zacks Investment Research — June 25, 2025PBF Energy outpaces rivals with a 12.9% gain, but weak renewables exposure and cautious analyst price targets signal caution.
Abacus Global Management, Inc. (ABL) Shares Tumble Following Second Morpheus Report - Hagens Berman — Neutral
ABL PRNewsWire — June 25, 2025SAN FRANCISCO , June 25, 2025 /PRNewswire/ -- Abacus Global Management, Inc. (NASDAQ: ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research—a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
3 High-Yield Dividend Kings Beating the S&P 500 This Year — Positive
CVS O VZ 24/7 Wall Street — June 25, 2025The S&P 500 is one of the most widely known benchmarks. It contains the 500 most valuable publicly traded U.S.
INVESTOR ALERT: Investigation of Myriad Genetics, Inc. (MYGN) Announced by Holzer & Holzer, LLC — Neutral
MYGN GlobeNewsWire — June 25, 2025ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Myriad Genetics, Inc. (“Myriad Genetics” or the “Company”) (NASDAQ: MYGN) complied with federal securities laws. On May 6, 2025, Myriad Genetics reported first quarter 2025 financial results, and lowered its 2025 financial guidance, revealing, among other things, a decline in pharmacogenomics revenue by 20% year-over-year “due to UnitedHealthcare (UNH) reduc[ing] coverage of GeneSight.” Following this news, the price of the Company's stock dropped.
All You Need to Know About Ermenegildo Zegna (ZGN) Rating Upgrade to Buy — Positive
ZGN Zacks Investment Research — June 25, 2025Ermenegildo Zegna (ZGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Betterware de Mexico SAPI de C (BWMX) Upgraded to Strong Buy: Here's What You Should Know — Positive
BWMX Zacks Investment Research — June 25, 2025Betterware de Mexico SAPI de C (BWMX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What Makes Veeva (VEEV) a New Strong Buy Stock — Positive
VEEV Zacks Investment Research — June 25, 2025Veeva (VEEV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
CVB Financial (CVBF) Upgraded to Buy: Here's What You Should Know — Positive
CVBF Zacks Investment Research — June 25, 2025CVB Financial (CVBF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BioCryst (BCRX) Upgraded to Strong Buy: What Does It Mean for the Stock? — Positive
BCRX Zacks Investment Research — June 25, 2025BioCryst (BCRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Hilltop Holdings (HTH) Upgraded to Buy: Here's What You Should Know — Positive
HTH Zacks Investment Research — June 25, 2025Hilltop Holdings (HTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Candel Therapeutics (CADL) Upgraded to Strong Buy: Here's What You Should Know — Positive
CADL Zacks Investment Research — June 25, 2025Candel Therapeutics (CADL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About ResMed (RMD) Rating Upgrade to Buy — Positive
RMD Zacks Investment Research — June 25, 2025ResMed (RMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Solaris Energy Infrastructure, Inc. (SEI) Upgraded to Buy: Here's What You Should Know — Positive
SEI Zacks Investment Research — June 25, 2025Solaris Energy Infrastructure, Inc. (SEI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why Manchester United (MANU) is a Great Momentum Stock to Buy — Positive
MANU Zacks Investment Research — June 25, 2025Does Manchester United (MANU) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ferguson plc (FERG) is a Great Momentum Stock: Should You Buy? — Positive
FERG Zacks Investment Research — June 25, 2025Does Ferguson plc (FERG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Evercore (EVR) is a Great Momentum Stock: Should You Buy? — Positive
EVR Zacks Investment Research — June 25, 2025Does Evercore (EVR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Inter & Co. Inc. (INTR) is a Great Momentum Stock: Should You Buy? — Positive
INTR Zacks Investment Research — June 25, 2025Does Inter & Co. Inc. (INTR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Sterling Infrastructure (STRL) is a Great Momentum Stock: Should You Buy? — Positive
STRL Zacks Investment Research — June 25, 2025Does Sterling Infrastructure (STRL) have what it takes to be a top stock pick for momentum investors? Let's find out.
